Cytoskeletal Dynamics in Pancreatic Cancer Metastasis
Cytoskeletal Dynamics in Pancreatic Cancer Metastasis
批准号:
8658003
负责人:
MARK A. MC NIVEN
金额:
$26.74万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-08-01 至 2015-04-30
关键词:
ActininActinsAdhesionsAnimal ModelAttenuatedBindingCell AdhesionCell PolarityCell membraneCell surfaceCellsCellular MembraneComplexCultured CellsCytoskeletonDataDiseaseDistalDorsalDynaminDynamin 2EndosomesEpidermal Growth Factor ReceptorExhibitsExtracellular MatrixFamilyFocal AdhesionsGoalsGuanosine Triphosphate PhosphohydrolasesHumanIn SituIn VitroInvadedLinkLocationMalignant NeoplasmsMalignant neoplasm of pancreasManuscriptsMediatingMembraneMethodsModificationMolecularMonomeric GTP-Binding ProteinsNeoplasm MetastasisOncogenesOncogenicOpticsOrganOrganellesPancreasPatientsPeripheralPhenotypePhosphotransferasesPlayProcessProliferatingPropertyProteinsPublishingReceptor Protein-Tyrosine KinasesRoleSamplingSignal TransductionSiteSorting - Cell MovementStress FibersStructureSupporting CellSurvival RateTechnologyTestingTissuesTumor Cell InvasionTumor Cell LineUbiquitinabstractingbasecell growthcell motilitygenetic regulatory proteinhuman EMS1 proteinimprovedin vivoinhibitor/antagonistmetastatic processmigrationneoplasticneoplastic cellnoveloutcome forecastpancreatic neoplasmpreclinical studyprotein activationprotein complexprotein crosslinkreceptor internalizationsrc-Family Kinasestumor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract
Pancreatic cancer is a devastating disease with an exceptionally poor prognosis. Tumors of ductular origin
comprise 95% of pancreatic neoplasms and have strong tendencies to invade surrounding parenchyma and
metastasize to distal organs. Currently, the molecular mechanisms that support these critical processes are
poorly defined. It is known that the actin cytoskeleton plays an important role and responds dynamically to
stimulation by a family of Receptor Tyrosine Kinases (RTKs) that are upregulated significantly in many
pancreatic tumors. This is a proposal to study the mechanisms by which RTKs activate dramatic reorganization
of the actin cytoskeleton, which alters cell polarity and leads to cell migration, invasion, and metastasis. We
have identified a key regulatory cytoskeletal complex in these cells composed of; a large mechanochemical
GTPase called dynamin (Dyn2) that is markedly upregulated in human pancreatic tumors, the actin
crosslinking protein cortactin, and the transforming kinase Src, which is activated by RTKs and binds and
phosphorylates both Dyn2 and cortactin. Importantly, we have shown that this complex associates with the
actin cytoskeleton, cellular membranes, as well as known oncogenic proteins implicated in pancreatic cancer
to form "signaling platforms" that support the invasive process. Our recent manuscripts and unpublished
observations provide strong support for the CENTRAL HYPOTHESIS of this study: mainly, the Dyn2-Cort-Src
complex, in concert with the oncogenic proteins ¿-actinin and Rac, is activated by elevated RTK cascades to
mediate actin-plasma membrane dynamics that promote invasion and metastasis of neoplastic pancreatic
ductular cells. This proposal will utilize state-of-the-art optical and molecular methods applied to pancreatic
tumor cell lines, tissue micro-array (TMA) technology of human tumor samples, and in vivo animal models to
define the molecular mechanisms by which this protein complex potentiates pancreatic neoplasia and
metastasis. This proposal is organized into three distinct but related specific aims that will define the following;
first, how these signaling platforms mediate large-scale internalization of RTKs from the cell surface to alter
cell signaling cascades; second, how the Dyn2-Cort-Src complex mediates major actin reorganization in tumor
cells that become migratory and invasive; and third, how tumor cell adhesion complexes form and proliferate
to mediate degradation of the surrounding extracellular matrix to facilitate metastasis. This study will make
close correlations between isolated cells and human tumors to provide novel information toward understanding
the molecular mechanisms that make pancreatic tumors so aggressive, migratory, and lethal. In addition, it
describes pre-clinical trials using novel, recently identified pharmacological inhibitors.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Investigation of a mitochondria-associated metastasis regulatory mechanism
-
批准号:10693170
-
项目类别:
-
资助金额:$35.64万
-
财政年份:2021
-
负责人:MARK A. MC NIVEN
-
依托单位:
Fast super-resolution/confocal microscopy for GI cell biology
-
批准号:10173129
-
项目类别:
-
资助金额:$60.0万
-
财政年份:2021
-
负责人:MARK A. MC NIVEN
-
依托单位:
Investigation of a mitochondria-associated metastasis regulatory mechanism
-
批准号:10209266
-
项目类别:
-
资助金额:$36.37万
-
财政年份:2021
-
负责人:MARK A. MC NIVEN
-
依托单位:
Core A: Administrative Core
-
批准号:10493808
-
项目类别:
-
资助金额:$13.6万
-
财政年份:2018
-
负责人:MARK A. MC NIVEN
-
依托单位:
Core A: Administrative Core
-
批准号:10707676
-
项目类别:
-
资助金额:$13.76万
-
财政年份:2018
-
负责人:MARK A. MC NIVEN
-
依托单位:
Developmental Research Program
-
批准号:10468833
-
项目类别:
-
资助金额:$5.73万
-
财政年份:2018
-
负责人:MARK A. MC NIVEN
-
依托单位:
Core A: Administrative Core
-
批准号:10468826
-
项目类别:
-
资助金额:$35.71万
-
财政年份:2018
-
负责人:MARK A. MC NIVEN
-
依托单位:
Mayo Clinic Hepatobiliary SPORE
-
批准号:10411346
-
项目类别:
-
资助金额:$10.92万
-
财政年份:2018
-
负责人:MARK A. MC NIVEN
-
依托单位:
Core A: Administrative Core
-
批准号:10006076
-
项目类别:
-
资助金额:$30.13万
-
财政年份:2018
-
负责人:MARK A. MC NIVEN
-
依托单位:
Mayo Clinic Hepatobiliary SPORE
-
批准号:10005922
-
项目类别:
-
资助金额:$229.42万
-
财政年份:2018
-
负责人:MARK A. MC NIVEN
-
依托单位:
Mayo Clinic Hepatobiliary SPORE
-
批准号:10527395
-
项目类别:
-
资助金额:$13.76万
-
财政年份:2018
-
负责人:MARK A. MC NIVEN
-
依托单位:
Core A: Administrative Core
-
批准号:10493805
-
项目类别:
-
资助金额:$10.92万
-
财政年份:2018
-
负责人:MARK A. MC NIVEN
-
依托单位:
Core A: Administrative Core
-
批准号:10251129
-
项目类别:
-
资助金额:$28.41万
-
财政年份:2018
-
负责人:MARK A. MC NIVEN
-
依托单位:
Mayo Clinic Hepatobiliary SPORE
-
批准号:10251127
-
项目类别:
-
资助金额:$194.07万
-
财政年份:2018
-
负责人:MARK A. MC NIVEN
-
依托单位:
Mayo Clinic Hepatobiliary SPORE
-
批准号:10468825
-
项目类别:
-
资助金额:$211.69万
-
财政年份:2018
-
负责人:MARK A. MC NIVEN
-
依托单位:
Mayo Clinic Hepatobiliary SPORE Diversity Supplement Dr. Musa Gabere
-
批准号:10310895
-
项目类别:
-
资助金额:$13.6万
-
财政年份:2018
-
负责人:MARK A. MC NIVEN
-
依托单位:
Developmental Research Program
-
批准号:10251137
-
项目类别:
-
资助金额:$7.31万
-
财政年份:2018
-
负责人:MARK A. MC NIVEN
-
依托单位:
Novel therapeutic inhibition of the Rac oncogene in pancreatic cancer
-
批准号:8186136
-
项目类别:
-
资助金额:$7.89万
-
财政年份:2011
-
负责人:MARK A. MC NIVEN
-
依托单位:
Novel therapeutic inhibition of the Rac oncogene in pancreatic cancer
-
批准号:8298132
-
项目类别:
-
资助金额:$7.89万
-
财政年份:2011
-
负责人:MARK A. MC NIVEN
-
依托单位:
Tumor Microenvironment/Angiogenesis Training Grant
-
批准号:8680175
-
项目类别:
-
资助金额:$25.36万
-
财政年份:2010
-
负责人:MARK A. MC NIVEN
-
依托单位:
海外基金